Equities

AJJ Medtech Holdings Ltd

AJJ Medtech Holdings Ltd

Actions
Consumer DiscretionaryConsumer Services
  • Price (SGD)0.004
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change-42.86%
  • Beta0.3609
Data delayed at least 10 minutes, as of Nov 13 2024 00:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SGD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.410.173.67
Total Receivables, Net0.870.711.01
Total Inventory0.960.540.32
Prepaid expenses------
Other current assets, total----0
Total current assets2.241.424.99
Property, plant & equipment, net1.071.562.24
Goodwill, net--00.27
Intangibles, net0.070.020.04
Long term investments0.010.010.01
Note receivable - long term0.050.05--
Other long term assets------
Total assets3.443.067.54
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt1.0200
Current portion long-term debt/capital leases0.720.280.44
Other current liabilities, total0.430.060.01
Total current liabilities3.430.840.75
Total long term debt0.951.031.10
Total debt2.691.311.54
Deferred income tax0.010.000.29
Minority interest0.12(0.07)(0.07)
Other liabilities, total0.270.060.03
Total liabilities4.781.862.10
SHAREHOLDERS EQUITY
Common stock434343
Additional paid-in capital------
Retained earnings (accumulated deficit)(44)(42)(37)
Treasury stock - common------
Unrealized gain (loss)----0
Other equity, total0.000.000.01
Total equity(1.33)1.205.44
Total liabilities & shareholders' equity3.443.067.54
Total common shares outstanding934934934
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.